Biodexa Pharmaceuticals (BDRX) Inventory Average (2016 - 2018)

Biodexa Pharmaceuticals has disclosed Inventory Average across 3 years of filings, most recently posting $1.1 million for Q4 2018.

• In Q4 2018, Inventory Average fell 10.45% year-over-year to $1.1 million; the TTM figure through Dec 2018 stood at $1.1 million (down 10.45% YoY), while the FY2018 annual figure was $1.0 million, down 11.56% from the prior year.
• Inventory Average came in at $1.1 million for Q4 2018 at Biodexa Pharmaceuticals, down from $1.3 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.3 million in Q2 2018 to a low of $913407.8 in Q2 2016.
• Average Inventory Average over 3 years is $1.1 million, with a median of $1.1 million recorded in 2017.
• Year-over-year, Inventory Average advanced 19.46% in 2017 and fell 10.45% in 2018.
• Over 3 years, Inventory Average stood at $1.1 million in 2016, then rose by 12.58% to $1.2 million in 2017, then retreated by 10.45% to $1.1 million in 2018.
• Per Business Quant data, the three most recent Inventory Average figures were $1.1 million in Q4 2018, $1.3 million in Q2 2018, and $1.2 million in Q4 2017.